Walker Neal bought ACRS
January 2, 2026 · Form 4 insider transaction
Walker Neal bought 29,150 shares of Aclaris Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
29,150
Price
N/A
Total value
N/A
InsiderWalker Neal
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 2, 2026
Filing dateJanuary 5, 2026
Shares owned after1,508,974
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.